P300 subcomponents reflect different aspects of psychopathology in schizophrenia
- PMID: 9894583
- DOI: 10.1016/s0006-3223(98)00108-5
P300 subcomponents reflect different aspects of psychopathology in schizophrenia
Abstract
Background: The aim of the study was to investigate abnormalities of P300 subcomponents in schizophrenic patients as well as relationships between these subcomponents and positive versus negative schizophrenic symptoms.
Methods: Nineteen schizophrenic patients and 19 healthy controls were tested with an auditory event-related potential oddball paradigm designed to elicit the P300. The P300 data were analyzed by separating P300 subcomponents with a recently developed dipole source model.
Results: Compared to healthy controls, schizophrenic patients showed reduced P300 amplitudes of the temporo-basal dipoles, corresponding mainly to P3b. Positive symptoms of the Positive and Negative Syndrome Scale correlated positively with the temporo-basal but not with temporo-superior dipole P300 activities, whereas negative symptoms correlated positively with the temporo-superior but not with temporo-basal dipole activities.
Conclusions: The P300 subcomponents separated with the dipole model are affected in a different manner by positive versus negative symptoms. Furthermore, the positive correlation between the severity of psychopathology and the P300 amplitudes of the different dipole activities appears to be a state-dependent effect, which has to be separated from the P300 amplitude reduction as a trait marker in schizophrenic patients.
Similar articles
-
P300 and symptom improvement in schizophrenia.Psychopharmacology (Berl). 2001 Oct;158(1):55-65. doi: 10.1007/s002130100835. Psychopharmacology (Berl). 2001. PMID: 11685384 Clinical Trial.
-
P300 subcomponents and clinical symptoms in schizophrenia.Int J Psychophysiol. 2002 Mar;43(3):237-46. doi: 10.1016/s0167-8760(01)00182-9. Int J Psychophysiol. 2002. PMID: 11850089 Clinical Trial.
-
P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology.Biol Psychiatry. 1998 Jan 15;43(2):84-96. doi: 10.1016/S0006-3223(97)00258-8. Biol Psychiatry. 1998. PMID: 9474441 Clinical Trial.
-
Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: cross-sectional and retrospective longitudinal studies.Schizophr Res. 2003 Feb 1;59(2-3):147-57. doi: 10.1016/s0920-9964(01)00397-8. Schizophr Res. 2003. PMID: 12414071
-
Theory, methods and new directions in the psychophysiology of the schizophrenic process and schizotypy.Int J Psychophysiol. 2003 May;48(2):221-45. doi: 10.1016/s0167-8760(03)00055-2. Int J Psychophysiol. 2003. PMID: 12763575 Review.
Cited by
-
Delayed preattentional functioning in early psychosis patients with cannabis use.Psychopharmacology (Berl). 2012 Aug;222(3):507-18. doi: 10.1007/s00213-012-2676-2. Epub 2012 Mar 9. Psychopharmacology (Berl). 2012. PMID: 22402706
-
Multimodal effects of local context on target detection: evidence from P3b.J Cogn Neurosci. 2009 Sep;21(9):1680-92. doi: 10.1162/jocn.2009.21071. J Cogn Neurosci. 2009. PMID: 18702574 Free PMC article.
-
Neurophysiological biomarkers for drug development in schizophrenia.Nat Rev Drug Discov. 2008 Jan;7(1):68-83. doi: 10.1038/nrd2463. Nat Rev Drug Discov. 2008. PMID: 18064038 Free PMC article. Review.
-
Biomarkers for the effects of antipsychotic drugs in healthy volunteers.Br J Clin Pharmacol. 2001 Feb;51(2):119-32. doi: 10.1111/j.1365-2125.2001.01308.x. Br J Clin Pharmacol. 2001. PMID: 11259983 Free PMC article. Review.
-
P300 in schizophrenia: Then and now.Biol Psychol. 2024 Mar;187:108757. doi: 10.1016/j.biopsycho.2024.108757. Epub 2024 Feb 3. Biol Psychol. 2024. PMID: 38316196 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous